This site is intended for health professionals only

Third-phase success for RA drug

teaser

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

Roche has presented yet more positive data from the third late-stage study of its experimental compound for rheumatoid arthritis, Actemra






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x